Gene Editing Could Become the Next “Golden Rush” in the Pharmaceutical Industry, What Does This Mean for CRISPR Therapeutics?

Life Science

This ETF Outperformed the S&P 500 in a Bear Market, Is It Worth Buying Today?

Consumer Goods, Financial Service

Defense Stocks Unexpectedly Weaken, Bernstein Analyzes Capital Rotation and Election Risks

Financial Service, Technology

3 Popular U.S. High-Dividend ETFs: Income, Growth and Diversification

Consumer Goods, Financial Service, Life Science, Technology

Alphabet Sets Record $84.75 Billion Financing, AI Computing Arms Race Escalates 

Technology

Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge

Life Science

Long-Term Holders Begin Selling, Bitcoin Bear Market May Be Nearing Its End

Cryptocurrency, Technology

Broadcom’s AI Revenue Surges 143% in Q2, Yet Shares Tumble Post-Earnings

Technology

USAR Secures $1.6B CHIPS Funding and $1.2B Factory, With Huge Risks Remaining

Mining

Gold Frenzy Fades: Inflation Becomes Bullion’s Biggest Headwind

Precious Metals

SpaceX IPO Set for June 12, Red Flags Cast Doubt on $1.75T Valuation

Technology

AbbVie Faces a Challenger in Johnson & Johnson, but Investors Need Not Panic

Life Science

Growth Stocks Meta and Dexcom Are Suitable for Buying and Holding Long-Term

Life Science

Gold Becomes Central Banks’ Top Reserve Asset Globally, but ECB Warns of Doubtful Sustainability

Mining, Precious Metals

Multiple Tailwinds Propel Broadcom Stock Surge as Market Eyes Its AI Chip Prospects

Technology